Preclinical prediction of Alzheimer's disease using SPECT

Abstract

SPECT data gathered and analyzed in this manner may be useful as one aspect of the preclinical prediction of AD. Three of the four brain regions important for discriminating Converters from normal controls involve a distributed brain network pertaining to memory, suggesting that this network may be selectively affected in the earliest stages of AD.

Keywords

Spect imagingAlzheimer's Disease Neuroimaging InitiativePosterior cingulateSingle-photon emission computed tomographyThalamusNeuroscienceAnterior cingulate cortexMedicineNeuroimagingInternal medicineAlzheimer's diseaseEmission computed tomographyPerfusionPsychologyNuclear medicineCardiologyCognitionDisease

Affiliated Institutions

Related Publications

Single-photon emission computed tomography

G.F. Knoll

The subject of singl-photon emission computed tomography (SPECT) is generally reviewed. The basic interaction processes of gamma rays in matter are outlined, and the formation o...

1983 Proceedings of the IEEE 63 citations

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI

Michael D. Greicius , Gaurav Srivastava , Allan L. Reiss +1 more

Recent functional imaging studies have revealed coactivation in a distributed network of cortical regions that characterizes the resting state, or default mode, of the human bra...

2004 Proceedings of the National Academy o... 3652 citations

Brain injury biomarkers are not dependent on β‐amyloid in normal elderly

David S. Knopman , Clifford R. Jack , Heather J. Wiste +10 more

Objective The new criteria for preclinical Alzheimer disease (AD) proposed 3 stages: abnormal levels of β‐amyloid (stage 1), stage 1 plus evidence of brain injury (stage 2), and...

2012 Annals of Neurology 179 citations

Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

Ronald Killiany , Teresa Gómez‐Isla , Mark B. Moss +7 more

We used magnetic resonance imaging (MRI) measurements to determine whether persons in the prodromal phase of Alzheimer's disease (AD) could be accurately identified before they ...

2000 Annals of Neurology 651 citations

[<sup>18</sup>F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid‐β pathology

Dietmar Rudolf Thal , Thomas G. Beach , Michelle Zanette +5 more

Abstract Background Amyloid positron emission tomography (PET) has become an important tool to identify amyloid‐β (Aβ) pathology in Alzheimer's disease (AD) patients. Here, we d...

2015 Alzheimer s & Dementia 149 citations

Publication Info

Year: 1998
Type: article
Volume: 50
Issue: 6
Pages: 1563-1571
Citations: 465
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Preclinical prediction of Alzheimer's disease using SPECT

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

465

OpenAlex

Cite This

APA Style

                            
                                
                                    Keith A. Johnson, 
                                
                                    Kelvyn Jones, 
                                
                                    B.L. Holman
                                
                                et al.
                            
                            (1998). 
                            Preclinical prediction of Alzheimer's disease using SPECT. 
                            Neurology
                            , 50
                            (6)
                            , 1563-1571.
                            https://doi.org/10.1212/wnl.50.6.1563
                        

Identifiers

DOI: 10.1212/wnl.50.6.1563